Investor Relations

Stock Quote

About SWK Holdings

We are a specialized finance company with a specific focus on opportunities in the global healthcare sector. We provide innovative capital solutions to a broad range of life science companies, institutions and inventors.

We provide capital to our business partners through our own balance sheet as well as through our investment advisory clients, which include family offices and institutional investors. Our broad capital base positions us to be the partner of choice for life science entities looking for flexible, nontraditional sources of capital.

Our management team has extensive experience specifically in healthcare-related principal investing and structured finance, resulting in a deep understanding of business opportunities in the life science sector.

For our investors, we expect to provide superior risk-adjusted returns on capital by investing in marketed ethical product cash flow streams.

Latest News
May 11, 2022

In the news release, SWK Holdings Corporation Announces Financial Results for First Quarter 2022, issued 11-May-2022 by SWK Holdings Corporation over PR Newswire, we are advised by the company...

May 10, 2022

Conference Call and Live Audio Webcast Scheduled for Wednesday, May 11, 2022, at 10:00 a.m. ET DALLAS, May 10, 2022 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH) ("SWK" or the...

May 04, 2022

Enteris BioPharma, Inc., a biotechnology company developing innovative drug products based on its proprietary delivery technologies, and a wholly-owned subsidiary of SWK Holdings Corporation...

View All Releases

Latest Presentation

Fall Investor Summit Webcast and Presentation
September 16, 2019

Listen to Webcast

Upcoming & Recent Events
Wednesday, May 11, 2022
10:00am - 11:00am EDT

View all Events

Contact Us

Maureen McEnroe
Tiberend Strategic Advisors, Inc.
(212) 375-2664


To see news related to SWK Holdings' Portfolio, click here.

Latest Quarterly Results